1887

Journal of General Virology header logo

Volume 69, Issue 8

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus Free

Abstract

Summary

Non-neutralizing, serotype-specific anti-NS1 monoclonal antibodies partially protected passively immunized mice from lethal dengue 2 virus intracerebral challenge. There was no apparent correlation between complement-fixing activity and protective capacity among individual anti-NS1 monoclonal antibodies. Immunization with specific combinations of non-protective or partially protective antibodies resulted in prolonged survival or reduced mortality. Solid protection, equal to that achieved after immunization with neutralizing polyclonal antibody, was achieved only with an antibody pair which individually fixed complement to high titre with homologous virus. Some groups of mice had increased morbidity after immunization with combinations of protective monoclonal antibodies that bind to overlapping epitopes. These results may affect the design of recombinant dengue vaccines which may require the inclusion of serotype-specific antigenic domains.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): dengue 2 virus , flaviviruses and passive protection
© Society for General Microbiology 1988
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-8-2101
1988-08-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/8/JV0690082101.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-8-2101&mimeType=html&fmt=ahah

References

  1. BOERE W. A. M., BENAISSA-TROUW B. J., HARMSEN T., ERICH T., KRAAIJEVELD C. A., SNIPPE H. 1985; Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. Journal of Virology 54:546–551
     [Google Scholar]
  2. BRANDRISS M. W., SCHLESINGER J. J., WALSH E. E., BRISELLI M. 1986; Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. Journal of General Virology 67:229–234
     [Google Scholar]
  3. BRANDT W. E., BUESCHER E. L., HETRICK F. M. 1967; Production and characterization of arbovirus antibody in mouse ascitic fluid. American Journal of Tropical Medicine and Hygiene 16:339–347
     [Google Scholar]
  4. CENTERS FOR DISEASE CONTROL 1981 A Guide to the Performance of the Standardized Diagnostic Complement Fixation Method and Adaptation to Micro Test Revised February 1981 Atlanta: Centers for Disease Control;
     [Google Scholar]
  5. CLARKE D. H., CASALS J. 1958; Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. American Journal of Tropical Medicine and Hygiene 7:561–573
     [Google Scholar]
  6. FALKER W. A., DIWAN A. R., HALSTEAD S. B. 1973; Human antibody to dengue soluble complement-fixing (SCF) antigens. Journal of Immunology 111:1804–1809
     [Google Scholar]
  7. GENTRY M. K., HENCHAL E. A., MCCOWN J. M., BRANDT W. E., DALRYMPLE J. M. 1982; Identification of distinct antigenic determinants on dengue-2 virus by using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 31:548–555
     [Google Scholar]
  8. GOULD E. A., BUCKLEY A., BARRETT A. D. T., CAMMACK N. 1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
     [Google Scholar]
  9. HALSTEAD S. B., CASALS J., SHOTWELL H., PALUMBO N. 1973; Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. American Journal of Tropical Medicine and Hygiene 22:365–374
     [Google Scholar]
  10. HEINZ F. X., BERGER R., TUMA W., KUNZ C. 1983; A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126:525–537
     [Google Scholar]
  11. HENCHAL E. A., GENTRY M. K., MCCOWN J. M., BRANDT W. E. 1982; Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. American Journal of Tropical Medicine and Hygiene 31:830–836
     [Google Scholar]
  12. HENCHAL E. A., BRANDT W. E., MCCOWN J. M., GENTRY M. K., REPIK P. B., PADMANABHAN R. K. 1984 Recent advances in the molecular biology of the dengue viruses. Proceedings of the International Conference on Dengue and Dengue Haemorrhagic Fever, September 1-3 1983, Kuala Lumpur47–71 Edited by Pand T., Pathmanathan R. Kuala Lumpur: University of Malaya;
     [Google Scholar]
  13. HENCHAL E. A., MCCOWN J. M., BURKE D. S., SEGUIN M. C., BRANDT W. E. 1985; Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 34:162–169
     [Google Scholar]
  14. HENCHAL E. A., HENCHAL L. S., THAISOMBOONSUK B. K. 1987; Topological mapping of unique epitopes on the dengue-2 virus NS1 protein using monoclonal antibodies. Journal of General Virology 68:845–851
     [Google Scholar]
  15. HENGARTNER H., LUZZATI A. L., SCHREIER M. 1978; Fusion of in vitro immunized lymphoid cells with X63Ag8. Current Topics in Microbiology and Immunology 81:92–99
     [Google Scholar]
  16. KENNETT R. H., DENIS K. A., TUNG A. S., KLINMAN N. R. 1978; Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells. Current Topics in Microbiology and Immunology 81:77–91
     [Google Scholar]
  17. MATHEWS J. H., ROEHRIG J. T. 1984; Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of St. Louis encephalitis virus by passive transfer of monoclonal antibodies. Journal of Immunology 132:1533–1537
     [Google Scholar]
  18. MONATH T. P. 1986 Pathobiology of the flaviviruses. The Togaviridae and Flaviviridae375–440 Edited by Schlesinger S., Schlesinger M. New York & London: Plenum Press;
     [Google Scholar]
  19. PORTERFIELD J. S. 1980 Antigenic characteristics and classification of Togaviridae. The Togaviridae13–46 Edited by Schlesinger R. W. New York & London: Academic Press;
     [Google Scholar]
  20. PRICE W. H., CASALS J., THIND I., O’LEARY W. 1973; Sequential immunization procedure against group B arboviruses using living attenuated 17D yellow fever virus, living attenuated langat E5 virus, and living attenuated dengue-2 virus (New Guinea C isolate). American Journal of Tropical Medicine and Hygiene 22:509–523
     [Google Scholar]
  21. QURESHI A. A., TRENT D. W. 1973; Group B arbovirus structural and nonstructural antigens. III. Serological specificity of solubilized intracellular viral proteins. Infection and Immunity 8:993–999
     [Google Scholar]
  22. REED L. J., MUENCH H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
     [Google Scholar]
  23. RUSSELL P. K., CHIEWSILP D., BRANDT W. E. 1970; Immunoprecipitation analysis of soluble complement-fixing antigens of dengue virus. Journal of Immunology 105:838–845
     [Google Scholar]
  24. SCHLESINGER J. J., BRANDRISS M. W., WALSH E. E. 1985; Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. Journal of Immunology 135:2805–2809
     [Google Scholar]
  25. SCHLESINGER J. J., BRANDRISS M. W., WALSH E. E. 1987; Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. Journal of General Virology 68:853–857
     [Google Scholar]
  26. SCHMALJOHN A. L., JOHNSON E. D., DALRYMPLE J. M., COLE G. A. 1982; Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature, London 297:70–72
     [Google Scholar]
  27. SMITH C. E. G., WESTGARTH D. R. 1956; The use of survival time in the analysis of neutralization tests for serum antibody surveys. Journal of Hygiene 55:224–238
     [Google Scholar]
  28. WALKER P. J., HENCHAL E. A., BLOK J., REPIK P. M., HENCHAL L. S., BURKE D. S., ROBBINS S. J., GORMAN B. M. 1988; Variation in dengue type 2 viruses isolated in Bangkok during 1980. Journal of General Virology 69:591–602
     [Google Scholar]
  29. WHITEHEAD R. H., CHAICUMPA V., OLSON L. C., RUSSELL P. K. 1970; Sequential dengue virus infections of white-handed gibbon (Hylobates lar). American Journal of Tropical Medicine and Hygiene 19:94–102
     [Google Scholar]
  30. WISSEMAN C. L., KITAOKA M., TAMIYA T. 1966; Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 15:588–600
     [Google Scholar]
  31. ZOLLINGER W. D., DALRYMPLE J. M., ARTENSTEIN M. S. 1976; Analysis of parameters affecting the solid phase radioimmune assay quantitation of antibody to meningococcal antigens. Journal of Immunology 117:1788–1798
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-8-2101
Loading
Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus
J. Gen. Virol. 69, 2101 (1988); https://doi.org/10.1099/0022-1317-69-8-2101
/content/journal/jgv/10.1099/0022-1317-69-8-2101
/content/journal/jgv/10.1099/0022-1317-69-8-2101
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error